Umbilical Cord Blood Bank

Cord Blood Stem Cells News

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meetingWednesday, March 3, 2010 @ 6:04AMCellular Dynamics International (CDI) and Hoffmann-La Roche Inc. (Roche) today announced a workshop to be held during the Society of Toxicology Annual Meeting in Salt Lake City, UT, on March 7 - 11.

Presentations on Geron's Telomerase Inhibitor At AACR Special ConferenceTuesday, March 2, 2010 @ 6:30AMMENLO PARK, Calif.----Geron Corporation today announced several presentations at the American Association for Cancer Research Special Conference on The Role of Telomeres and Telomerase in Cancer Research held in Fort Worth, TX between February 27th and March 1st.

Cord blood: a wasted lifeline?Monday, March 1, 2010 @ 6:27PMToday, all things being about average, 2,000 babies will be born in Britain, or roughly one every 80 seconds. Almost without exception, their umbilical cords will be clamped, cut – and incinerated. And this, say a growing number of parents and health professionals, is waste so flagrant it borders on the criminal. Far from being dead on arrival, these sinewy flexes are potential lifelines long ...

Determining personal risk for genetic disorders essentialMonday, March 1, 2010 @ 4:49AMGenetic diseases affect an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by the Genetic Disease Foundation (GDF), while two-thirds of those surveyed were willing to and saw the benefits of undergoing genetic testing, close to 80 percent had never talked to their physician about genetic screening – an inconsistency that can have serious implications on a ...

Fate Therapeutics named to Technology Review's 2010 TR50 most innovative companies in the world listFriday, February 26, 2010 @ 7:50AMFate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies ...

New treatments for heart diseaseWednesday, February 24, 2010 @ 2:11AMTwo studies published in the latest issue of Cell Transplantation (18:12) may lead to new treatments for the treatment of heart diseases. The first study, carried out by a team of Brazilian researchers, found that cell transplantation of bone marrow mononuclear cells (BMMCs) directly into the heart benefited patients suffering from refractory angina.

AmStem Corporation Announces Ticker Symbol Change to AMST Effective TodayTuesday, February 23, 2010 @ 12:20PMTAMPA, FL--(Marketwire - February 23, 2010) - AmStem Corporation ( OTCBB : AMST ) announces that it has received approval from the Financial Industry Regulatory Authority (FINRA) for the Company's name change to AmStem Corporation from Stem Cell Therapy International and for its ticker symbol change to AMST from SCII as quoted on the Over the Counter Bulletin Board effective today, February 23 ...

Aldagen Announces Strategic Management ChangesTuesday, February 23, 2010 @ 9:35AMRichard Kent, M.D. Appointed to Chairman of the Board; Leadership Strengthened as Products Advance Through Clinical Trials

Aldagen Announces Strategic Management ChangesTuesday, February 23, 2010 @ 9:20AMDURHAM, NC--(Marketwire - 02/23/10) - Aldagen, Inc. today announced strategic management changes to better position the company as it advances clinical development of its product pipeline. Effective immediately, Richard Kent, M.D. will join Aldagen's Board of Directors and will become Chairman of the Board. Dr. Kent is a venture partner at Intersouth Partners, and has 27 years of experience in ...